GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maravai LifeSciences Holdings Inc (STU:MAR) » Definitions » Additional Paid-In Capital

Maravai LifeSciences Holdings (STU:MAR) Additional Paid-In Capital : €123.7 Mil(As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Maravai LifeSciences Holdings Additional Paid-In Capital?


Maravai LifeSciences Holdings's quarterly additional paid-in capital increased from Sep. 2023 (€117.2 Mil) to Dec. 2023 (€117.8 Mil) and increased from Dec. 2023 (€117.8 Mil) to Mar. 2024 (€123.7 Mil).

Maravai LifeSciences Holdings's annual additional paid-in capital increased from Dec. 2021 (€113.6 Mil) to Dec. 2022 (€130.2 Mil) but then declined from Dec. 2022 (€130.2 Mil) to Dec. 2023 (€117.8 Mil).


Maravai LifeSciences Holdings Additional Paid-In Capital Historical Data

The historical data trend for Maravai LifeSciences Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maravai LifeSciences Holdings Additional Paid-In Capital Chart

Maravai LifeSciences Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial - 69.97 113.62 130.18 117.84

Maravai LifeSciences Holdings Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 106.77 110.67 117.21 117.84 123.72

Maravai LifeSciences Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Maravai LifeSciences Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Maravai LifeSciences Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Maravai LifeSciences Holdings (STU:MAR) Business Description

Traded in Other Exchanges
Address
10770 Wateridge Circle, Suite 200, San Diego, CA, USA, 92121
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.